Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,338 | -2,402 | N/A | -3,420 | -2,797 |
| Depreciation Amortization | 114 | 58 | N/A | 260 | 295 |
| Accounts receivable | -44 | -24 | N/A | -7 | -51 |
| Accounts payable and accrued liabilities | 604 | 241 | N/A | -252 | 96 |
| Other Working Capital | 621 | 92 | N/A | -440 | -672 |
| Other Operating Activity | 1,470 | 812 | 0 | 362 | 992 |
| Operating Cash Flow | $-2,573 | $-1,223 | $N/A | $-3,497 | $-2,137 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -25 | N/A |
| PPE Investments | -6 | -1 | N/A | 642 | 700 |
| Net Acquisitions | N/A | -169 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -418 | N/A | N/A | -411 | -262 |
| Other Investing Activity | -418 | 0 | 0 | -411 | -262 |
| Investing Cash Flow | $-424 | $-170 | $N/A | $206 | $438 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 623 | N/A | N/A | N/A |
| Debt Issued | 1,314 | N/A | N/A | N/A | -1 |
| Debt Repayment | N/A | N/A | N/A | -2 | N/A |
| Common Stock Issued | 1,126 | 87 | N/A | 3,963 | 1,657 |
| Financing Cash Flow | $2,440 | $710 | $N/A | $3,961 | $1,656 |
| Exchange Rate Effect | -12 | -10 | N/A | 30 | 27 |
| Beginning Cash Position | 900 | 900 | N/A | 405 | 470 |
| End Cash Position | 331 | 207 | N/A | 1,105 | 454 |
| Net Cash Flow | $-569 | $-693 | $N/A | $700 | $-16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,573 | -1,223 | N/A | -3,497 | -2,137 |
| Capital Expenditure | -6 | -1 | N/A | -37 | -26 |
| Free Cash Flow | -2,579 | -1,224 | 0 | -3,534 | -2,163 |